IL5 and allergic asthma: A previous study indicated that FMT 10 mg/kg administrated by intraperitoneal injection could significantly alleviate AHR and decrease Th2 cytokines (IL-4, IL-5, and IL-13) levels in the HDM-induced inflammation of allergic asthma (Yuan et al., 2020).